Freestone Capital Holdings, LLC Gsk PLC Transaction History

Freestone Capital Holdings, LLC

$2.9 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$42.05 - $47.77 $3.9 Million - $4.43 Million	-92,713 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $264,512 - $313,890	6,575 Added 7.63%	92,713 $4.04 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $90,940 - $105,980	-2,339 Reduced 2.64%	86,138 $3.8 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $19,472 - $21,666	502 Added 0.57%	88,477 $3.38 Million
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $11,394 - $12,935	-312 Reduced 0.35%	87,975 $3.5 Million
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $130,705 - $152,598	-3,814 Reduced 4.14%	88,287 $3.15 Million
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $841,733 - $986,757	24,706 Added 36.66%	92,101 $3.39 Billion
Q3 2020 Nov 06, 2020	SELL	$38.11 - $42.99 $301,640 - $340,265	-7,915 Reduced 10.51%	67,395 $2.59 Million
Q2 2020 Aug 04, 2020	BUY	$37.87 - $43.58 $96,189 - $110,693	2,540 Added 3.49%	75,310 $3.07 Million
Q1 2020 May 12, 2020	SELL	$32.47 - $48.83 $1.95 Million - $2.94 Million	-60,194 Reduced 45.27%	72,770 $2.76 Million
Q4 2019 Feb 04, 2020	SELL	$42.0 - $48.25 $1.85 Million - $2.12 Million	-43,993 Reduced 24.86%	132,964 $6.25 Million
Q3 2019 Nov 07, 2019	SELL	$40.46 - $43.52 $2.18 Million - $2.35 Million	-53,893 Reduced 23.35%	176,957 $7.55 Million
Q2 2019 Aug 05, 2019	SELL	$39.4 - $42.7 $1.15 Million - $1.24 Million	-29,085 Reduced 11.19%	230,850 $9.24 Million
Q1 2019 May 08, 2019	SELL	$38.57 - $42.69 $717,633 - $794,290	-18,606 Reduced 6.68%	259,935 $10.9 Million
Q4 2018 Feb 12, 2019	BUY	$37.8 - $42.69 $235,834 - $266,342	6,239 Added 2.29%	278,541 $10.6 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $328,017 - $352,277	-8,252 Reduced 2.94%	272,302 $10.9 Million
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $473,458 - $511,110	11,953 Added 4.45%	280,554 $11.3 Million
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $6.52 Million - $7.23 Million	180,124 Added 203.58%	268,601 $10.5 Million
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $487,303 - $577,759	-13,789 Reduced 13.48%	88,477 $3.14 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $325,695 - $343,119	8,258 Added 8.78%	102,266 $4.15 Million
Q2 2017 Aug 15, 2017	BUY	N/A	94,008	94,008 $4.05 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Account